Noveko Wins Orders Worth $1.25 Million in Algeria
MONTREAL, Sept. 8, 2011 /CNW Telbec/ - Noveko International Inc. (TSX: EKO) (the "Company") is pleased to announce that its subsidiary SARL Noveko Algérie ("Noveko Algérie"), following a selection by way of a call for tenders by Algeria's National Office of Equipment and Accessories for Handicapped People ("the NOEAHP"), has won firm orders for the supply of medical devices (technical walking aids) worth a total of 1.25 million Canadian dollars at current prices. Deliveries of this equipment are scheduled to extend until December 31, 2011.
"We are very pleased to further build upon a partnership based on expertise and know-how sharing with the NOEAHP. Won following a rigorous selection process and fitting in with a business development framework, these new orders attest to the quality of our products and after-sales service as well as the renewed confidence of the NOEAHP. They also represent an additional example of the great potential of this market," indicated Mr. Mourad Ramdane, President and General Manager of Noveko Algérie.
The NOEAHP is a statutory body reporting to the Algerian Ministry of Labour and Social Security whose public mission is to meet the needs of people with disabilities and reduced mobility in order to favour their re-education, rehabilitation and social reintegration. To that end, the NOEAHP is responsible for the manufacture, distribution and maintenance of orthopedic devices, other technical walking aids, hearing aids as well as other medical equipment and accessories.
Noveko International Inc. offers innovative solutions in the environmental and medical fields worldwide. Through its subsidiaries, the Company specializes primarily in the following business segments: the development, manufacturing and marketing of derivative products from its patented antimicrobial filtration technologies, mainly air filters, surgical masks and respirators, as well as other products with antibacterial properties such as hand sanitizers - and the development, manufacturing and marketing of medical equipment, including portable real-time ultrasound scanners for use in human and veterinary medicine.
Certain statements set forth in this press release constitute forward-looking statements. In some cases, these statements are identified by the use of terms such as "may", "could", "might", "intend", "should", "expect", "project", "plan", "believe", "estimate" or other comparable variants. These statements are based on the information available at the time they are written, on assumptions made by management and on the expectations of management, acting in good faith, regarding future events, including those relating to economic conditions, fluctuations in exchange rates and operating expenses, and the absence of unusual events entailing supplementary expenditures. Although management considers these assumptions and expectations reasonable based on the information available at the time they are written, they could prove inaccurate. Forward-looking statements are also subject, by their very nature, to known and unknown risks and uncertainties such as those related to the industry, acquisitions, labor relations, credit, key officers, supply and product liability. The actual results of Noveko International Inc. could differ materially from those indicated or underlying these forward-looking statements. The reader is therefore recommended not to unduly rely on these forward-looking statements. Forward-looking statements do not reflect the potential impact of special items, any business combination or any other transaction that may be announced or occur subsequent to the date hereof. Unless otherwise required under securities laws, the Company does not intend and undertakes no obligation to update or revise the forward-looking statements to reflect new information, new events or new circumstances.
For further information:
Chantal Vennat, Director,
Investor Relations and Corporate Communications
Noveko International Inc.
Tel: (514) 875-0606